We encourage you to republish this article online and in print, it’s free under our creative commons attribution license, but please follow some simple guidelines:
  1. You have to credit our authors.
  2. You have to credit SciDev.Net — where possible include our logo with a link back to the original article.
  3. You can simply run the first few lines of the article and then add: “Read the full article on SciDev.Net” containing a link back to the original article.
  4. If you want to also take images published in this story you will need to confirm with the original source if you're licensed to use them.
  5. The easiest way to get the article on your site is to embed the code below.
For more information view our media page and republishing guidelines.

The full article is available here as HTML.

Press Ctrl-C to copy

Brazil's Amazon rainforest is teeming with life — an estimated 30 per cent of the planet's animal and plant species — that could yield raw materials for new medicines. Brazil fears that foreign researchers could exploit its biodiversity without paying the country a fair share of the profits.

As Michael Astor reports in this article, however, Brazilian efforts to deter such 'biopiracy' risk stifling both local and foreign research. The government's strict rules controlling research on Brazil's wild species have forced some scientists to move their projects to neighbouring Bolivia, Ecuador and Peru.

And although concerns about biopiracy are widespread in Brazil, a member of the congressional committee investigating it says they have not found evidence for even a single case.

Brazilian researchers interviewed in the article say Brazil does not have enough knowledge about the very biodiversity it is desperate to protect. They agree that the best way to protect the Amazon's biodiversity would be for Brazil to invest more in home-grown research.

Link to full article on